Molnupiravir-Associated Mutational Signature in Global SARS-CoV-2 Genomes, Inhaled Fluticasone Furoate for Outpatient Treatment of COVID-19, and Autonomic Dysregulation in Long-Term Patients Suffering from Post-COVID-19 Syndrome

6 views
October 5, 2023
0 Comments
Login to view comments. Click here to Login